Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Peripheral Neuropathies and Disorders, and Health Systems, Economic Evaluations, Quality of Life.
Completeness and generalizability of the Swedish MS register
<scp>COMBAT</scp>‐<scp>MS</scp>: A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
Validation of the Swedish Multiple Sclerosis Register
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients